Member Info for SocialistB

But because of the unknown answer:
DOES IT WORK?
There will be plenty of investors will not invest at this stage.
Neither when we get the PIND or IND and whats not.

No these people will first join when we get positive clinical results
And results are still out there in the future

Here's to hoping they are positive.

Or only on a few percentage of all virus.

We will find out.

And that is why fortune favours the brave.

If Mr. Sandler and his team gets this right, we will do VERY well indeed.

All that is needed from our side as investors is patience.

To be in this stock at this stage, with only access to the officially released information, you got to have a gambling side to your personality.

We do not know if CAR-T works in humans.

We will find out later.

We do not know if CBR works in humans or only on

CBR
Clearly shows that timing does matter.
I mean, with seismic news like that, the share price should have rocket.
But it didn't.

Now imagine, the news had deliberately been held back until some time after (hopefully positive) news on CAR-T.

Then Hemogenyx would have been on everyone's radar and shown it is not one trick pony and can deliver the goods.

In other words, no need to wish for news for the sake of wishing for news.
CBR, clearly showed it does not work like that.

Be patient, that is the main requirement here.

I believe Me. Sandler got the science under control.

Should have said GOOD NEWS AT THAT STAGE

When is the best time for news.

In my opinion surely not this week.

It's school holidays. It's the week leading up to Easter/Passover.

I much prefer that any news would deliberately be hold back until next week, maybe even the following week.

I think there will be a better momentum in the market to better news at that stage.

What do you think?

@Bamps
It's just that I seems to recall him talking about that currently it was not possible to move to the main market, as they do not own their main activity outright (Havieron) and for that reason the easiest way to get access would be to buy a producing asset.
Main reason for me to go to the main market would be getting more institutonal investors on board.

@Bamps

Like you, I hope that they will keep Warrentina.

And I have a secret little wish that when Shaun Day was in London, he met up with financers and later on the good people from Begbies Traynor Group plc to hear about the possibilities of buying NQ Minerals out of administration.

Okay, so the Beaconsfield mine is probably more then a 100 Km away from the Forester licence and that might not make it easy for the transportation of the ore.

But at least we would get that producing asset that he was talking about, and that would enable us to move to the main market here in London, with the benefits that would add.

When the cash flow is rolling, it would be easier to build some facilities at Warrantina.

Just wishing out loud.

300 MILLION shares being sold between 1 and 1.5 pence, I doubt it.

A market appetite for such an eyewatering amount of shares would most definitely make the share price rocket.

I fail to understand the obsession about the 52 weeks high I see here and on other boards as well.

A hostile offer can come at any point.

But why settle for peanuts, with the trajectory Hemogenyx are on in a matter of months.

And it is up to us, the shareholders to decide if we will accept a lowball offer.

I sincerely hope the vast majority wont.

@JHFH
"The timing sucks, he should have waited until Hemo was on more solid ground before putting it on his LinkedIn account"

It is incredible how rarely I find myself disagreeing with your posts (borderline to scary), but I disagree with the above line.

I will rather 100 fold that he announces it now then later.

When people and the market wakes up to Hemogenyx eventually it has already been announced that Mr. Sandler has another project on the side line.

I could not see anything worse then when investors start flocking into Hemogenyx and becomes groupies of Mr. Sandler as first 1, then 2, then 3 products starts to hit the headlines, he announces a new project.

I would be totally scared of a sudden (hopefully short lived price correction) of say up to 50%.

Now that would hurt, if the share price had risen to say 5-7-10 pence at that time.

Could you imagine the profanities uttered on this board?

No, much better to get out of the way now.

Then we can always claim it is so yesteryears news:-)

PART 3

Tue, 30th Jun 2020 14:39
RNS Number : 5754R
Gunsynd PLC
30 June 2020

Result of GM, Issue of Equity and Director Dealing
“Director Dealing
As announced on 11 June 2020, Hamish Harris and Donald Strang, Directors of the Company, have, on the same terms as the Placees, subscribed for £39,000 in aggregate, being 6 million new ordinary shares in the placing representing 6.5% of the total Placing ("Director Participation"). The Director Participation shares have now been issued as part of the Conditional Placing. Further, as participants in the placing on the same terms as the Placees, Hamish Harris and Don Strang have each received Placing Warrants, issued at one warrant for every three ordinary shares subscribed for on the same terms as the Placees.”
https://www.lse.co.uk/rns/GUN/result-of-gm-issue-of-equity-and-director-dealing-z1396673us3wc9n.html

Mon, 6th Jul 2020 07:00
RNS Number : 0492S
Gunsynd PLC
06 July 2020

Placing to Raise £465,000
“Gunsynd (AIM: GUN, AQSE: GUN) announces that it has placed, through its broker, Peterhouse Corporate Finance ("Peterhouse"), 71,538,462 new ordinary shares to raise gross proceeds of approximately £465,000 (the "Placing"). The new ordinary shares have been placed at a price of 0.65 pence per share (the "Placing Price").
The placees will also receive one warrant for every three ordinary shares subscribed for, exercisable at 1.3 pence (the "Placing Warrants") and expiring on the one-year anniversary of the date of issue. In aggregate, 23,846,154 Placing Warrants will be issued.”
“Following Admission, the Company's issued share capital will comprise 238,367,047 Ordinary Shares with voting rights. “
https://www.lse.co.uk/rns/GUN/placing-to-raise-163465000-seqskdk6e5l2inp.html

Tue, 7th Jul 2020 07:00
RNS Number : 1846S
Gunsynd PLC
07 July 2020

Further Placing to Raise £104,000
“Further to the placings announced by the Company on 11 June 2020 and 6 July 2020, Gunsynd (AIM: GUN, AQSE: GUN) announces that, in order to satisfy excess investor demand, it has placed a further 16,000,000 new ordinary shares to raise gross proceeds of approximately £104,000 (the "Placing"). The new ordinary shares have also been placed at a price of 0.65 pence per share (the "Placing Price").
In line with the placings announced on 11 June and 6 July, the places ("Placees") will also receive one warrant for every three ordinary shares subscribed for, exercisable at 1.3 pence (the "Placing Warrants") and expiring on the one-year anniversary of the date of issue. In aggregate, 5,333,334 Placing Warrants will be issued.”
“Following Admission, the Company's issued share capital will comprise 254,367,047 Ordinary Shares with voting rights. “
https://www.lse.co.uk/rns/GUN/further-placing-to-raise-163104000-lkao42da5275u45.html

PART 2

Without all shareholders being able to benefit from the placing price and attached warrants.

So following the simple example from before, if you held 1% of Gunsynd on May the 1st 2020, then by mid July 2020 your % would have shrunk to 0.29% or in other words, less then 1/3 of the % you had before. (this is assuming you were not invited to participate.

I think all shareholders should be allowed to participate.

So, please vote no to resolutions 4 and 5.

Please feel free to read the snippets of the RNS’ mentioned below. Or even better look them up yourself.

Mon, 4th May 2020 14:26
RNS Number : 8550L
Gunsynd PLC
04 May 2020

Following the passage of the resolutions at the GM today, 6,334,275,841 Existing Ordinary Shares of 0.001 pence each in issue in the capital of the Company, together with the 64 additional Ordinary Shares issued on 1 May 2020 to ensure the Company's issued ordinary share capital is divisible by 85, will be consolidated into 74,520,893 New Ordinary Shares of 0.085 pence each

https://www.lse.co.uk/rns/GUN/result-of-gm-and-consolidation-of-share-capital-hwuz5z3ao49sulf.html

Thu, 11th Jun 2020 13:23
RNS Number : 7075P
Gunsynd PLC
11 June 2020
Placing and Conditional Placing to Raise £600,000
“Gunsynd (AIM: GUN, AQSE: GUN) announces that it has today placed, through its broker, Peterhouse Corporate Finance ("Peterhouse"), 92,307,692 new ordinary shares to raise gross proceeds of £600,000. “
https://www.lse.co.uk/rns/GUN/placing-and-conditional-placing-to-raise-163600000-61k6lz9p4evlvtg.html

Fri, 12th Jun 2020 15:23
RNS Number : 8631P
Gunsynd PLC
12 June 2020

“Subject to shareholder approval at the General Meeting for the requisite authorities, investors subscribing for Placing Shares will also receive one Placing Warrant for every three ordinary shares subscribed for, exercisable at 1.3 pence and expiring on the two-year anniversary of the date of issue. In aggregate, 30,769,231 Placing Warrants have been conditionally issued. Further, as part of the commission arrangements, the Broker has been issued with 2,769,231 warrants subject to shareholder approval for the requisite authorities, on the same terms as the Placing Warrants. “

https://www.lse.co.uk/rns/GUN/posting-of-circular-and-notice-of-general-meeting-vlggg63rnbsiuq3.html

Tue, 30th Jun 2020 14:39
RNS Number : 5754R
Gunsynd PLC
30 June 2020

Result of GM, Issue of Equity and Director Dealing
“Director Dealing
As announced on 11 June 2020, Hamish Harris and Donald Strang, Directors of the Company, have, on the same terms as the Placees, subscribed for £39,000 in aggregate, being 6 million new ordinary shares in the placing representing 6.5% of the total Placing ("Director Participation"). The Director Participation shares have now been issued as part of the Conditional Placing. Further, as participants in the placing on the same terms as the Placees, Hamish Harris and Don Strang have each received Placing

PART 1

On Thursday the 24-3-2022 we have an AGM, you can vote on the proposed resolutions, but the deadline is Tuesday the 22-3-2022 at 1100, unless you show up in person at the AGM.

I think it is worth having a discussion here over the weekend about the following resolutions:

Resolution 4 - Directors' Authority to Allot Shares
This is an ordinary resolution to grant to the Directors the authority to allot and issue shares and grant rights to subscribe for shares in the Company for the purposes of Section 551 of the Act up to the maximum aggregate nominal amount of £527,000 (representing 620,000,000 Ordinary Shares of 0.085 pence or approximately 138% of the current issued ordinary share capital of the Company). This Resolution replaces any existing authorities to issue shares in the Company and the authority under this Resolution will expire at the conclusion of the next annual general meeting of the Company.

Resolution 5 - Disapplication of Pre-emption Rights
Resolution 5 proposes to dis-apply the statutory rights of pre-emption in respect of the allotment of equity securities for cash under Section 561(1) of the Act. This is a special resolution authorising the Directors to issue equity securities as continuing authority up to an aggregate nominal amount of £527,000 (representing 620,000,000 Ordinary Shares of 0.085 pence or approximately 138% of the current issued ordinary share capital of the Company) for cash on a non-pre-emptive basis pursuant to the authority conferred by Resolution 4 above. The authority granted by this Resolution will expire at the conclusion of next annual general meeting of the Company.

Based on my past experience, I advocate that you vote a resounding NO, to these 2 resolutions.

It is incredible annoying to see your percentage go down, when the directors line people up to buy the shares at a cheap price and last time they did so, it was with warrants attached.
But an existing shareholder you are not invited to participate.

Just a light example:

A company has 100 shares in circulation.
You are the lucky owner of 1 share or 1% of the company.

Now the directors decide to increase the amount of shares to 238 shares in circulation. (increase of 138% as suggested)
But you are not given the chance to get even a single one of those 138 new shares.

So now you only have 1 share out of 238 and your percentage of the company have fallen from 1% to 0.42% (1/238*100=0.42%)

All of a sudden your %, whatever it might be, has more then halved.

It is less then 2 years since it last happened.

Just a brief re-cap:

In the beginning of 2020 Gunsynd had more then 6 BILLION shares in circulation.
This was divided by 85 and resulted in circa 74,5 million shares in circulation.
So far, so good. You still had the same % as before.
But from May 4th 2020 to July 7th 2020, a time frame of just slightly more then 2 months, the number of shares went from 74 million to 254 million (Only counted

PART 2

All it takes, is for the science to work. (not a small task in itself)

Well actually not, there is more that is needed. A SOLID resistance to any low ball offer of a take out.

Resistance works. Long live Ukraine.

PART 1

Like so many others I am gobsmacked by the lack of response from the market after the fantastic news on Wednesday the 16-3-2022.

A novel treatment, possible against all virus infections. Albeit modifications has to be made depending on the virus, according to my understanding.

But unlike so many others, I am happy with the low share price.

I along with fellow other readers on this forum, are now in possession of information that is available to the whole wide world.

But we are the few lucky ones, who have a change to act on the wonderful news that has come out of New York this week, as everyone else seems to be oblivious to the amazing news.

I for one appreciate that Mr. Sandler and the BOD are true to their word. They gave an update when there was one to give.

And as it has turned out, I am very pleased with the lack of information available about CBR online.

I knew CBR existed. I knew Mr. Sandler was very happy about it’s progression.
But after Wednesday, now I officially know it works in the lab. And so many more details.
(I would never have guessed that B was for BAIT, who uses such a delightful simple word in medicine)
And I hope, trust, believe and want it to work in humans. (however that is still to be found out)

Had Mr. Sandler and the BOD already prepared information in any form or shape, then other people would have been in the know and it might have affected the share price, before I could buy more at this insane low price.

And this is why I am so gobsmacked. The share price went up about 11% Wednesday, so it will have been pretty highly placed on the rising share index.

High enough, that it ought to have caught traders and investors eye’s alike. It baffles me that people have not read the accompanied RNS and jumped in straight away, without to much thinking.

But maybe, we should appreciate that. It could have let to to many one line dreadful hyping post’s.

Being the purely greedy bastard that I am, I would not mind another 2-4 weeks at this level. It will give me another change to top up.

I mean, this share is an absolute steal at this price. (if the science works, of course:-)

So, be glad that you are now one of the few that is sitting with knowledge about a potential breakthrough in the medical world (if it works) and you can buy this share for around 1.5 pence

What is not to like.

I have told a few friends and family members that they ought to look into this company, because it could be a game changer.

Especially if Hemogenyx start to license it out to various companies. And hopefully not exclusively, as I like competition, it brings the price down and that is good for the citizens of the world.

If, and it is big IF, CBR works on almost all viruses or just 50% of them, then this is a game changer of astronomical proportions.

And my hope of £4, 10 years from now would make many a soul jealous. They would happily give their right arm to have that as an entry pr

And yet somene is complaining about the share price falling. Of course it is in so uncertain times. I doubt there is a single investor who is not underwater at present.

Please post a informative post once in a while, when you have unearth some good information.

I am sure we are many who will appreciate it.

@JustHereForHemo, I totally get what you are saying, but I will miss most of your posts as many of them have been informative. You have presented (and so have others) information and provided links to information that I would not have come across myself with the words that I put into a search engine.
The information you and others provide, is the reason I check in on this board on a daily basis, it is nice to be educated.
So here is a big thank you to you (and others) for the research and not least links provided, so we can check up for us self.
If you do not want to engage with certain members on this board I fully get it, but I for one will really miss your informative post's, if which there has been many, and I would urge you to post from time to time and just not engage with those individuals who drag down your mood.
Leave them be, we have all made our own choices and are accountable ourselves. If people do not have the spine to stomach the hard and testing times, then so be it.
I mean, we now unfortunately have a mad man residing in Kremlin, we could potentially be on the brink of a nuclear war within years

Will we get a RNS in the next couple of days?

Personally, I do not need one.
I think it would be a waste of money, because I am of the opinion that getting a negative feedback from FDA would be deemed price sensitive information and would therefore have to be announced via a RNS.

Hence why I would interpretate no news as nothing but a positive responce from FDA. Especially in combination with the new job advertisement.

At a yearly salary of 90.000, there is a good reason to keep the purse strings tight, when possible. (And rather make the savings on something as mundane as an RNS, then our employees salary, Christmas dinner and other feel good options)

So, I am happy not to receive a RNS and happy to wait for the bomber RNS that says they are now ready to start clinical trials.

Sometimes, no news is good news.
And I think this is such an occasion.

So I say, save the money, as we can read between the lines and should the share price continue to stay low, well that is just my luck. One day closer to my next paycheck and the possibility for another little top up.

@HereforHemo, I really can’t disagree with a single word that you have said.
The CLN was a calamity to the share price.
To me, that question is not even up for discussion.

And that was the reason, why I sold a significant amount of my shares in Hemogenyx some time after I heard about the CLN, and with a loss.

I really do not like CLN’s.

Back then, I was afraid that Hemogenyx could be taken over. If I remember correctly, then the CLN’s could amount to 3 times the number of shares that Hemogenyx had in circulation at that point, if they were to be cashed in under the most favorable conditions.

Time went by, and my fear did not prove to be correct, and so I started to add to my holding again. And I have continued to do so, on the way down. Always thinking it does not get much cheaper then this (boy, has I wrong on many occasions) hence why, like so many others here, I sit on a huge loss, should I choose to sell up at this stage.

I wont however. Call it stubbornness, faith, hope or whatever you want.

It just so happens, that I like the way Mr. Sandler conduct himself. And I might be reading to much into it, because this is the way I want to see it.

But I much prefer to be invested in a company with a CEO who does not feel like spending money on RNS’ about everything and nothing in the hope to increase the share price.

To me it is integrity, when you want the results to speak for themselves. Instead of loads of RNS’ about nothing of substance just with the hope of increasing the share price.

And since no one will accuse Mr. Sandler of that, I feel I am in good hands here.

Added bonus, I feel he has listened to the critique and increased the PR with interviews and so forth, maybe not successfully from the share price point, but I get to know him a bit better each time and I appreciate that.

@JustHereForHemo, as with HereforHemo, I can’t really disagree with a word you say (and generally I don’t, please keep your often well researched and thoughtful posts coming)
But I liked your take on Minty better a couple of day’s ago, when you talked about how things might not have worked out as he expected and suddenly found himself in a different situation then expected.

It gave me things for thought and I must admit, had I been in a situation where I had lend out millions and expected to get them back in a short time, with a very good return, and then the deal falls through.
Well then I might have done exactly what Minty did. Thinking that any true investor would get their investment back and they would get the opportunity to buy in cheaper as well.

And that is why, annoying as it is to sit with a way to high loss for my liking, I am still chuffed to bits.

Had the share price been trading in the 5-7 pence ratio, I would not have the amount of shares I do.

So, I am happy because there was a fantastic opportunity and I have been able to take advantage.

If you participate in a placing and all the money goes to the company (minus expenses) then you could possibly claim a high moral ground and say that you are doing it to support science. And that you do not care about the share price. And the statement would carry some merit.

For the rest of us, it becomes near impossible to claim that, as we are just buying from the next John Doe, and no money is landing in the coffers of Hemogenyx as a result of that transaction.

So it would not be unfair to conclude, that most of us are here to turn a profit.

Hence the headline: What camp are you in when it comes to turning a profit.

1. You wish you had never bought into Hemogenyx or even better then that, would be to never have heard of the company.

2. You see the current low price as an opportunity to get a high number of shares, expecting them to multiply several times over on good news or even better, on good clinical results.

Whatever camp you’re in, I am sure no one is enjoying sitting on a 30-40-50-60% loss.

Could Dr. Vladislav Sandler have done things differently: YES

Should he have done things differently: NO

Okay, so that last answer is a bit provocative and deliberately so.

But from my personal point of view, had the price not dropped down to sub 2 pence level, there is no way on earth that I would have been able to accumulate the number of shares that I have today.
I have managed to multiply the dream target that I had this time last year, many times over.

So, despite a huge loss, I am chuffed to bits.

This is a buying opportunity. And has been for a long time.

And I, for purely selfish reasons, do not mind if it stays here a little while longer, until another one of my shares comes good, and I can move the profit over here, at these prices.

So, I am very happy with the RNS’ that we have had in 2021 and Dr. Sandler's communication and not least his priorities.

I will much rather have a man at the helm who focuses on what really matters.
Create treatments that works.

If, he and his team are successful in this matter, then the money will follow automatically (at least that is my expectation)

In 2021 the foundation has been laid to the clinical trial that we will soon hear more about.

I am excited about the outcome. If it is good, then everybody is a winner, even the one who I will be selling a part of my allocation to, because it will just rise and rise (with setbacks along the way)